BACE-1 inhibition by a series of ψ[CH 2NH] reduced amide isosteres
A new class of β-secretase inhibitors that incorporate a reduced amide transition state isostere as the key binding element is described. The incorporation of a 5-substituted isophthalamide scaffold at the N-terminal site of this isostere resulted in potent compounds that display impressive cellular...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2006-07, Vol.16 (14), p.3635-3638 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A new class of β-secretase inhibitors that incorporate a reduced amide transition state isostere as the key binding element is described. The incorporation of a 5-substituted isophthalamide scaffold at the N-terminal site of this isostere resulted in potent compounds that display impressive cellular IC
50 values. The syntheses and BACE-1 activities of these inhibitors are reported.
A series of β-site amyloid precursor protein cleaving enzyme (BACE-1) inhibitors containing a ψ(CH
2NH) reduced amide bond were synthesized. Incorporation of this reduced amide isostere as a non-cleavable peptide surrogate afforded inhibitors possessing low nanomolar potencies in both an enzymatic and cell-based assay. |
---|---|
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2006.04.076 |